Over the years, shareholders at the Interfaith Center on Corporate Responsibility (ICCR) have repeatedly voiced concerns on a variety of subjects to top pharma companies. Now, as 2023 comes to a close, the group is taking pharma giants to task over their patenting strategies and potential human rights shortfalls.
The post Activist shareholders urge drugmakers to re-evaluate patent strategies, human rights policies first appeared on Interfaith Center on Corporate Responsibility.
